We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $3.64B
1-Year Est. Return 83.38%
This Fund
S&P 500
This Quarter Est. Return
+49.74%
1 Year Est. Return
+83.38%
3 Year Est. Return
+239.61%
5 Year Est. Return
+330.19%
10 Year Est. Return
+1,383.86%
AUM
$3.64B
AUM Growth
+$913M
Cap. Flow
+$245M
Cap. Flow %
6.73%
Top 10 Hldgs %
40.93%
Holding
1,250
New
158
Increased
429
Reduced
585
Closed
75

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$72.2M
2
AVGO icon
Broadcom
AVGO
+$27.9M
3
SNDK
Sandisk
SNDK
+$15M
4
AAPL icon
Apple
AAPL
+$13.9M
5
MU icon
Micron Technology
MU
+$12.9M

Sector Composition

Rank Sector Weight
1 Technology 56.05%
2 Healthcare 8.58%
3 Communication Services 8.31%
4 Consumer Discretionary 7.81%
5 Industrials 3.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARQT icon
326
Arcutis Biotherapeutics
ARQT
$3B
$1.09M 0.03%
41,655
-40,088
-49% -$934K
TT icon
327
Trane Technologies
TT
$98.5B
$1.09M 0.03%
2,218
+63
+3% +$29.5K
DD icon
328
DuPont de Nemours
DD
$17.8B
$1.08M 0.03%
7,967
+4,055
+104% +$576K
SNDX icon
329
Syndax Pharmaceuticals
SNDX
$1.84B
$1.08M 0.03%
49,412
-6,492
-12% -$135K
MO icon
330
Altria Group
MO
$115B
$1.08M 0.03%
14,985
-1,930
-11% -$135K
RBLX icon
331
Roblox
RBLX
$30.9B
$1.08M 0.03%
19,817
-1,417
-7% -$70.5K
CLDX icon
332
Celldex Therapeutics
CLDX
$3.12B
$1.08M 0.03%
28,930
-596
-2% -$19.3K
ACN icon
333
Accenture
ACN
$114B
$1.07M 0.03%
8,612
+1,230
+17% +$214K
SPGI icon
334
S&P Global
SPGI
$131B
$1.07M 0.03%
2,626
-98
-4% -$41.4K
NIO icon
335
NIO
NIO
$9.52B
$1.06M 0.03%
209,428
+3,737
+2% +$21.8K
HL icon
336
Hecla Mining
HL
$13.9B
$1.06M 0.03%
68,654
-31,977
-32% -$562K
MLYS icon
337
Mineralys Therapeutics
MLYS
$2.49B
$1.06M 0.03%
39,225
-2,759
-7% -$75.7K
RCL icon
338
Royal Caribbean
RCL
$70.9B
$1.05M 0.03%
3,314
-5
-0.2% -$1.4K
AGIO icon
339
Agios Pharmaceuticals
AGIO
$1.98B
$1.05M 0.03%
28,260
-17,534
-38% -$532K
BBD icon
340
Banco Bradesco
BBD
$36.7B
$1.05M 0.03%
301,608
-38,067
-11% -$139K
COF icon
341
Capital One
COF
$135B
$1.05M 0.03%
5,215
-174
-3% -$33.3K
EQIX icon
342
Equinix
EQIX
$102B
$1.04M 0.03%
996
+4
+0.4% +$4.28K
CB icon
343
Chubb
CB
$132B
$1.03M 0.03%
3,022
-114
-4% -$37.2K
FFIV icon
344
F5
FFIV
$22.1B
$1.02M 0.03%
2,460
-31
-1% -$11K
CX icon
345
Cemex
CX
$15.9B
$1.02M 0.03%
85,144
-15,985
-16% -$198K
AGI icon
346
Alamos Gold
AGI
$15.5B
$1.01M 0.03%
33,453
-11,972
-26% -$485K
MCK icon
347
McKesson
MCK
$106B
$1.01M 0.03%
1,339
-28
-2% -$22.2K
VRDN icon
348
Viridian Therapeutics
VRDN
$2.6B
$1.01M 0.03%
54,773
-8,568
-14% -$138K
LMT icon
349
Lockheed Martin
LMT
$121B
$1M 0.03%
1,966
+62
+3% +$33.5K
SHEL icon
350
Shell
SHEL
$266B
$1,000K 0.03%
12,891
-373
-3% -$32.2K

Similar funds

Profund Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Profund Advisors held 1,250 positions worth $3.64B, up 34% from $2.72B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Profund Advisors deployed $245M of net new capital in Q2 2026, opening 158 new positions and adding to 429 existing holdings. Its largest new stake was Honeywell Aerospace: 24,902 shares worth $5.51M.

By sector, the portfolio is most concentrated in Technology at 56% of assets, up from 43% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Honeywell, an estimated $5.34M trimmed.

  • Profund Advisors's largest Q2 2026 buy was Honeywell Aerospace: 24,902 shares worth $5.51M.
  • Profund Advisors added most to NVIDIA in Q2 2026, an estimated $72.2M increase.
  • Profund Advisors's biggest Q2 2026 reduction was Honeywell, cutting an estimated $5.34M.
  • Profund Advisors fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $3.27M.
  • Profund Advisors's ten largest holdings make up 41% of its $3.64B portfolio in Q2 2026.
  • Profund Advisors opened 158 new positions and closed 75 in Q2 2026.
  • Profund Advisors's portfolio value rose 34% quarter-over-quarter to $3.64B.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.